AIM Cancellation - Summit Therapeutics PLC (7948D)
2020年2月24日 - 4:00PM
RNSを含む英国規制内ニュース (英語)
TIDMSUMM
RNS Number : 7948D
AIM
24 February 2020
NOTICE
24/02/2020
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON
At the request of the Company the following securities have been
cancelled from trading on AIM with effect from the time and date of
this notice.
SUMMIT THERAPEUTICS PLC
213800NRW8AOMYMTBD89
ORDINARY SHARES (BN40HZ0)(GB00BN40HZ01) SUMT THER/PAR VTG FDP 0.01
OF 1P EACH, FULLY
PAID
----------------------- --------------------------
If you have any queries or require further information, please
contact the company's nominated adviser +44 (0)20 7213 0880.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AMOUASVRRRUUUAR
(END) Dow Jones Newswires
February 24, 2020 02:00 ET (07:00 GMT)
Summit Therapeutics (LSE:SUMM)
過去 株価チャート
から 8 2024 まで 9 2024
Summit Therapeutics (LSE:SUMM)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Summit Therapeutics Plc (ロンドン証券取引所): 0 recent articles
その他のSummit Therapeutics Plcニュース記事